COST-EFFECTIVENESS OF VILDAGLIPTIN COMPARED TO GENERIC SULPHONYLUREAS ADDED ON TO METFORMIN FROM THE PORTUGUESE SOCIETAL PERSPECTIVE

被引：1
|
作者：
Calado, F. [1 ]
Gruenberger, J. B. [2 ]
Silva-nunes, J. [3 ]
Carvalho, D. [4 ]
机构：
[1] Novartis, Sintra, Portugal
[2] Novartis, Basel, Switzerland
[3] Curry Cabral Hosp, Lisbon, Portugal
[4] S Joao Hosp, Fac Med, Oporto, Portugal
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.1688
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A501 / A501
页数：1
相关论文
共 50 条
  • [41] COST-EFFECTIVENESS OF SECUKINUMAB COMPARED TO USTEKINUMAB IN PATIENTS WITH PSORIASIS FROM A SWEDISH HEALTH CARE PERSPECTIVE
    Costa-Scharplatz, M.
    Lang, A.
    Gustavsson, A.
    Fasth, A.
    VALUE IN HEALTH, 2015, 18 (07) : A422 - A422
  • [42] COST-EFFECTIVENESS ANALYSIS OF SECUKINUMAB IN ANKYLOSING SPONDYLITIS IN BIOLOGIC-NAIVE PATIENTS FROM THE PORTUGUESE PERSPECTIVE
    Laires, P.
    Silva, C.
    Esparteiro, J.
    Fonseca, J. E.
    VALUE IN HEALTH, 2019, 22 : S699 - S699
  • [43] Cost-effectiveness of hypertension therapy based on 2020 International Society of Hypertension guidelines in Ethiopia from a societal perspective
    Davari, Majid
    Sorato, Mende Mensa
    Kebriaeezadeh, Abbas
    Sarrafzadegan, Nizal
    PLOS ONE, 2022, 17 (08):
  • [44] COST-EFFECTIVENESS OF FIXED-DOSE COMBINATION (FDC) OF VILDAGLIPTIN/METFORMIN FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2 IN MEXICO
    Lemus, A.
    Jimenez Aranda, P.
    VALUE IN HEALTH, 2013, 16 (07) : A689 - A689
  • [45] COST-EFFECTIVENESS ANALYSIS OF USING HYPOGLYCEMIC AGENTS (LINAGLIPTIN, SAXAGLIPTIN, SITAGLIPTIN, VILDAGLIPTIN, GLIMEPIRIDE AND GLIBENCLAMIDE) WITH METFORMIN IN DIABETES IN COLOMBIA
    Romero, M.
    Marrugo, R.
    Sanchez, O.
    Lopez, S.
    Alvis, N.
    VALUE IN HEALTH, 2013, 16 (03) : A163 - A163
  • [46] Cost-effectiveness of lipegfilgrastim from the Mexican payer perspective
    Szende, A.
    Bussey, B.
    Szabo, E.
    Klastersky, J.
    Tomey, O.
    Mueller, U.
    Gabriel, S.
    Tang, B.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S117 - S117
  • [47] Cost-Effectiveness of Dipeptidylpeptidase-4 Inhibitors Added to Metformin in Patients With Type 2 Diabetes in China
    Lin, Wen-Qiang
    Cai, Zhong-jie
    Chen, Tingting
    Liu, Mao-Bai
    Li, Na
    Zheng, Bin
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [48] COST-EFFECTIVENESS OF CANAGLIFLOZIN VERSUS SITAGLIPTIN WHEN ADDED TO METFORMIN AND SULFONYLUREA IN TYPE 2 DIABETES IN CANADA
    Sabapathy, Suthakar
    Neslusan, Cheryl
    Yoong, Kim
    Teschemaker, Anna
    Johansen, Pierre
    Willis, Michael
    JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2016, 23 (02): : E151 - E168
  • [49] COST EFFECTIVENESS OF NIVOLUMAB-IPILIMUMAB COMBINATION THERAPY COMPARED TO MONOTHERAPY FOR METASTATIC MELANOMA FROM A US SOCIETAL PERSPECTIVE
    Tran, D. M.
    McDowell, L. C.
    Oh, A.
    Barcelon, J. A.
    Keyvani, D.
    Merino, O.
    Wilson, L.
    VALUE IN HEALTH, 2016, 19 (03) : A124 - A124
  • [50] Decision analysis to compare the cost-effectiveness of the statins available by prescription versus over the counter based from a societal perspective
    Gandhi, P
    McGhan, W
    Peterson, A
    VALUE IN HEALTH, 2006, 9 (03) : A123 - A123
12345